Is US FDA Preparing to Remove Some Fed Study Requirements For Generic Bioequivalence?
Executive Summary
New ICH draft guidance says a fed study is not necessary for most immediate-release solid oral dosage products and the FDA indicates it will consider revising product-specific guidances to harmonize standards.
You may also be interested in...
Generic Drug Pilot On Model-Informed Evidence Aims To Boost Review Efficiency
US FDA officials, hoping to kick start participation in the pilot, argue modeling decisions made early in development can help streamline the ANDA review later.
Generic Drug Pilot On Model-Informed Evidence Aims To Boost Review Efficiency
US FDA officials, hoping to kick start participation in the pilot, argue modeling decisions made early in development can help streamline the ANDA review later.
Supplemental Filings: Gene Therapy Harmonization Moving Ahead; US FDA’s COVID-19 EUA Authority Hanging Around
Peter Marks suggests the need for a ‘compromise’ on gene therapy. Elizabeth Sadove looks towards an extended tenure for COVID products under EUAs.